BackFirebrick Pharma Limited Overview

Firebrick Pharma Limited Receivables

Firebrick Pharma Limited's receivables is $50K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$50117.00
↓ 80.56% YoYΔ $-207693.00 vs prior year quarter

Peer trimmed avg / median

Loading

Firebrick Pharma Limited Receivables History

Loading

Firebrick Pharma Limited vs. peers: Receivables Comparison

Loading

Firebrick Pharma Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Firebrick Pharma Limited (FRE.AX) FAQ

As of the most recent data (June 2026), FRE.AX shows a receivables of $50K. That compares with $260K in the prior-year period — down 80.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FRE.AX's receivables is now $50K (was $260K) — a 80.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Firebrick Pharma Limited is outperforming or lagging.

Tracking FRE.AX's receivables over time shows whether Firebrick Pharma Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $50K That compares with $260K in the prior-year period — down 80.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Firebrick Pharma Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $50K) with ownership activity and broader fundamentals.